198 related articles for article (PubMed ID: 30610355)
1. Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.
Onbasi Y; Lettmaier S; Hecht M; Semrau S; Iro H; Kesting M; Fietkau R; Haderlein M
Strahlenther Onkol; 2019 Jun; 195(6):482-495. PubMed ID: 30610355
[TBL] [Abstract][Full Text] [Related]
2. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
Dagan R; Morris CG; Kirwan JM; Werning JW; Vaysberg M; Amdur RJ; Mendenhall WM
Laryngoscope; 2010 May; 120(5):945-52. PubMed ID: 20422688
[TBL] [Abstract][Full Text] [Related]
3. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
4. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
5. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
7. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
8. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Putz F; Iro H; Agaimy A; Fietkau R
Radiat Oncol; 2019 Apr; 14(1):68. PubMed ID: 31014362
[TBL] [Abstract][Full Text] [Related]
10. Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy.
Wirtz MM; Temming S; Kocher M; Kunze S; Semrau R
Strahlenther Onkol; 2020 May; 196(5):474-484. PubMed ID: 31832696
[TBL] [Abstract][Full Text] [Related]
11. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.
Ooishi M; Motegi A; Kawashima M; Arahira S; Zenda S; Nakamura N; Ariji T; Tokumaru S; Sakuraba M; Tahara M; Hayashi R; Akimoto T
Jpn J Clin Oncol; 2016 Oct; 46(10):919-927. PubMed ID: 27511989
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
14. Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer.
Hehr T; Classen J; Schreck U; Glocker S; Koitschev A; Bamberg M; Budach W
Strahlenther Onkol; 2002 Jul; 178(7):363-8. PubMed ID: 12163990
[TBL] [Abstract][Full Text] [Related]
15. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
[TBL] [Abstract][Full Text] [Related]
16. Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma.
Birkeland AC; Auerbach AD; Sanborn E; Parashar B; Kuhel WI; Chandrasekharappa SC; Smogorzewska A; Kutler DI
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):930-4. PubMed ID: 21930984
[TBL] [Abstract][Full Text] [Related]
17. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
[TBL] [Abstract][Full Text] [Related]
18. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
